AMN Healthcare Reports Officer Changes & Compensation Arrangements

Ticker: AMN · Form: 8-K · Filed: 2024-02-21T00:00:00.000Z

Sentiment: neutral

Topics: executive-change, compensation, 8-K

TL;DR

**AMN Healthcare just filed an 8-K about changes in its executive team and their pay, effective February 17, 2024.**

AI Summary

AMN Healthcare Services, Inc. filed an 8-K on February 21, 2024, reporting an event that occurred on February 17, 2024. The filing pertains to Item 5.02, specifically regarding the departure or election of directors or officers and compensatory arrangements for certain officers. The company, incorporated in Delaware with IRS Employer Identification No. 06-1500476, is headquartered at 2999 Olympus Boulevard, Suite 500, Dallas, Texas 75019.

Why It Matters

This filing signals potential shifts in leadership and executive compensation at AMN Healthcare, which could influence future strategic direction and financial performance.

Risk Assessment

Risk Level: low — This 8-K is a standard disclosure about executive changes and compensation, not indicating immediate financial distress or major operational shifts.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by AMN Healthcare Services, Inc.?

This 8-K filing, dated February 21, 2024, reports on an event that occurred on February 17, 2024, specifically concerning Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 17, 2024.

What is the full business address of AMN Healthcare Services, Inc. as stated in the filing?

The business address of AMN Healthcare Services, Inc. is 2999 Olympus Boulevard, Suite 500, Dallas, Texas 75019.

What is AMN Healthcare Services, Inc.'s state of incorporation?

AMN Healthcare Services, Inc. is incorporated in Delaware.

What is the company's SEC File Number?

The company's SEC File Number is 001-16753.

From the Filing

0000950142-24-000504.txt : 20240221 0000950142-24-000504.hdr.sgml : 20240221 20240221160738 ACCESSION NUMBER: 0000950142-24-000504 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240217 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMN HEALTHCARE SERVICES INC CENTRAL INDEX KEY: 0001142750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 061500476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16753 FILM NUMBER: 24659443 BUSINESS ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 BUSINESS PHONE: 8668718519 MAIL ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 8-K 1 eh240449846_8k.htm FORM 8-K false 0001142750 0001142750 2024-02-17 2024-02-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 17, 2024   AMN HEALTHCARE SERVICES, INC. (Exact name of registrant as specified in its charter)   Delaware 001-16753 06-1500476 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)       2999 Olympus Boulevard , Suite 500 Dallas , Texas 75019 (Address of principal executive offices) (Zip Code)   ( 866 ) 871-8519 (Registrant’s Telephone Number, Including Area Code)   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)         ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)         ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act  (17 CFR 240.14d-2(b))         ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act  (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   AMN   NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 17, 2024, Martha H. Marsh, a member of the board of directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) since 2010, notified the Board of her decision not to stand for re-election at the Company’s 2024 annual meeting of stockholders (the &#8220

View on Read The Filing